HCW Biologics Inc. Loss Contingency, Loss in Period
HCW Biologics Inc. (HCWB) reported Loss Contingency, Loss in Period of $1.30 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes
us-gaap:LossContingencyLossInPeriod · last filed 2024-11-14
- HCW Biologics Inc. loss contingency, loss in period for the quarter ending 2024-09-30 was $1.30M.
- HCW Biologics Inc. loss contingency, loss in period for the quarter ending 2024-06-30 was $1.30M.
| Period end | Loss Contingency, Loss in Period 3 month | Loss Contingency, Loss in Period 6 month | Loss Contingency, Loss in Period 9 month |
|---|---|---|---|
| 2024-09-30 | $1.30M 10-Q · filed 2024-11-14 | $2.60M derived: sum of 2 quarters · filed 2024-11-14 | $1.30M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.30M 10-Q · filed 2024-08-14 | $1.30M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |